ResearcherPeking University Third HospitalActive in the last 2 years

Limei Guo

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 8 November 2026

Matched on OpenAlex author ID A5124233448. Sources: OpenAlex.

Their work

Papers: 2 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2025: 1 paper · 2026: 1 paper

Papers 2

Characteristics of p53 and Smad4 immunohistochemistry in pancreatic ductal adenocarcinoma and validation by next-generation sequencing. Last author DOI 10.14670/hh-25-072 ↗
Baseline neutrophil-to-lymphocyte ratio (NLR) at the time of diagnosis of liver metastasis is an independent prognostic factor for patients with pancreatic can… Co-author DOI 10.21203/rs.3.rs-5765906/v1 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Ziqi Zhao · 1 shared paper, 2026 · strength 0.36
- Paper Characteristics of p53 and Smad4 immunohistochemistry in pancreatic ductal adenocarcinoma and validation by next-genera… DOI 10.14670/hh-25-072 ↗
Baoshan Cao · 1 shared paper, 2025 · strength 0.33
- Paper Baseline neutrophil-to-lymphocyte ratio (NLR) at the time of diagnosis of liver metastasis is an independent prognostic… DOI 10.21203/rs.3.rs-5765906/v1 ↗
Huiying Huang · 1 shared paper, 2025 · strength 0.33
- Paper Baseline neutrophil-to-lymphocyte ratio (NLR) at the time of diagnosis of liver metastasis is an independent prognostic… DOI 10.21203/rs.3.rs-5765906/v1 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.